Persistent Asset Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23
Closed -$1.85K 409
2025
Q3
$1.85K Sell
23
-34,577
-100% -$25.7M ﹤0.01% 232
2025
Q2
$474K Buy
34,600
+34,552
+71,983% +$26.8M 0.35% 79
2025
Q1
$215K Buy
+48
New +$39.9K 0.18% 98

Other funds holding LLY

Persistent Asset Partners's LLY Position: Q1 2026 in Review

Persistent Asset Partners increased its Eli Lilly (LLY) stake by 258% in Q1 2026, buying an estimated $1.39M and bringing the position to 1,906 shares worth $1.75M. The position accounts for 0.65% of the portfolio, ranked #39.

Persistent Asset Partners first reported a position in LLY in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.71M in Q1 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Persistent Asset Partners held 1,906 shares of Eli Lilly worth $1.75M as of Q1 2026.
  • Persistent Asset Partners bought 1,373 Eli Lilly shares in Q1 2026, an estimated $1.39M.
  • Eli Lilly made up 0.65% of Persistent Asset Partners's portfolio in Q1 2026, its #39 holding.
  • Persistent Asset Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 5 quarters since.
  • Persistent Asset Partners's Eli Lilly position peaked at $3.71M in Q1 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.